StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · MIRA·Healthcare

MIRA Pharmaceuticals, Inc. Stock Analysis & AI Score

MIRA Pharmaceuticals, Inc. (MIRA) has an ST Score of 35.5 (C-), driven by its Valuation (A-) and held back by its Profitability (F). Analysts rate it Buy.

Market Closed
$0.84
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
36
ST Score
35.5/100C-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

MIRA
35.5out of 100
Grade C-

MIRA Pharmaceuticals, Inc. (MIRA) has an ST Score of 35.5 (C-), driven by its Valuation (A-) and held back by its Profitability (F). Analysts rate it Buy.

Strongest
ValuationA-
Weakest
ProfitabilityF
All factor grades
  • ValuationA-
  • Financial StrengthA-
  • GrowthD+
  • MomentumD
  • ProfitabilityF
  • Piotroski2/9
Score methodology
Press Releases

Contact

MIRA stock: frequently asked questions

What is MIRA's ST Score?

MIRA Pharmaceuticals, Inc. (MIRA) has an ST Score of 35.5 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is MIRA a buy, hold, or sell?

Analysts rate MIRA a Buy. Our ST Score grades it C- (35.5/100). The ST Score is a data-driven signal, not a recommendation.

What are MIRA's factor grades?

Valuation A-, Profitability F, Financial Strength A-, Momentum D, Growth D+.

What is MIRA's valuation grade?

MIRA Pharmaceuticals, Inc. (MIRA) earns a valuation grade of A-, measured against Drug Manufacturers - General peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is MIRA's growth grade?

MIRA Pharmaceuticals, Inc. (MIRA) earns a growth grade of D+, measured against Drug Manufacturers - General peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is MIRA's profitability grade?

MIRA Pharmaceuticals, Inc. (MIRA) earns a profitability grade of F, measured against Drug Manufacturers - General peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is MIRA's financial strength grade?

MIRA Pharmaceuticals, Inc. (MIRA) earns a financial strength grade of A-, measured against Drug Manufacturers - General peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is MIRA's Piotroski score?

MIRA Pharmaceuticals, Inc. (MIRA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.